Search

Your search keyword '"Gschwantler, Michael"' showing total 495 results

Search Constraints

Start Over You searched for: Author "Gschwantler, Michael" Remove constraint Author: "Gschwantler, Michael"
495 results on '"Gschwantler, Michael"'

Search Results

1. ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in Austria

2. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure

5. Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)

8. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

10. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

11. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease

13. Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir

17. Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection

20. THU-381 Prognostic implications of liver stiffness impairment after HCV cure in cACLD patients

21. FRI-394 High burden of cirrhosis and increasing response rates to bulevirtide-based regimens: insights from the austrian prospective hepatitis D registry

24. Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria

26. Correction to: Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir

28. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study

29. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

31. ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in Austria

35. The risks of first hepatic decompensation and HCC remain constant during long-term follow-up and can be stratified by a one-time assessment after HCV-cure

36. Validation and refinement of the Baveno VII criteria for risk stratification in compensated advanced chronic liver disease after HCV-cure

39. Association of Interleukin-32 and Interleukin-34 with Cardiovascular Disease and Short-Term Mortality in COVID-19

40. Prevalence and dynamics of NAFLD-associated fibrosis in people living with HIV in Vienna from first presentation to last follow-up

43. HCV hotline facilitates Hepatitis C elimination during the COVID ‐19 pandemic

44. The ‘Viennese epidemic’ of acute HCV in the era of direct-acting antivirals

45. Virologic response to bulevirtide is delayed in cirrhotic HDV patients with clinically significant portal hypertension

46. Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-Results of a “real world study”

48. ELIMINATE-interim results of an Austrian HCV macro-elimination project

Catalog

Books, media, physical & digital resources